SCHEMBL17516257

SCHEMBL17516257

CC1CCN(C2CCN(C(=O)C(C)C)CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ADRA1A P35348 6/20 0.41
▸ CHRM2 P08172 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ CHRNB3 Q05901 1/20 0.40
▸ CHRNA6 Q15825 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ HPGD P15428 1/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ DPP8 Q6V1X1 1/20 0.38
▸ DPP7 Q9UHL4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19652287 0.90 ADRA1A (0.50) ALDH1A1MEN1KMT2ACYP3A4CYP2C19
SCHEMBL18267300 0.90 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ACYP3A4CYP2C19
SCHEMBL25604665 0.90 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ACYP3A4CYP2C19
SCHEMBL12449153 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AGAACHRNB2
SCHEMBL13615983 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AGAACHRNB2
SCHEMBL25107536 0.82 MEN1 (0.46) ALDH1A1MEN1KMT2ACYP3A4CYP2C19
SCHEMBL5020025 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AGAACHRNB2
SCHEMBL2606047 0.82 ALDH1A1 (0.70) ALDH1A1MEN1KMT2AGAACHRNB2
SCHEMBL13207242 0.81 KDM4E (0.42) ALDH1A1MEN1KMT2AADRA1AKDM4E
SCHEMBL25630791 0.81 CHRM1 (0.41) ALDH1A1MEN1KMT2ACYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809545-B2 Factor XIa inhibitors MERCK SHARP & DOHME CORP. (US) 2017-11-07 — — US disclosed
US-20160046581-A1 Factor XIa Inhibitors MERCK SHARP & DOHME CORP. (US) 2016-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046581-A1 Factor XIa Inhibitors F11, F12, TFPI ALDH1A1 2920/4885MEN1 1105/4885KMT2A 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback